Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
06:00:53 EDT Fri 29 Aug 2025
Enter Symbol
or Name
USA
CA



Q:PLSE - PULSE BIOSCIENCES INC - https://investors.pulsebiosciences.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
PLSE - Q0.114.14·16.344.115.56-0.29-1.8156.82,3091,75315.85  16.035  15.5025.00  13.7658Aug 28Aug 2615 min RT 2¢

Recent Trades - Last 10 of 1753
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-08-26 07:00U:PLSENews ReleasePulse Biosciences Announces Publication of First-In-Human Data for Treatment of Benign Thyroid Nodules in the Journal Thyroid
2025-08-12 16:05U:PLSENews ReleasePulse Biosciences Reports Business Updates and Second Quarter 2025 Financial Results
2025-08-01 07:00U:PLSENews ReleasePulse Biosciences To Present at the 45th Canaccord Genuity Annual Growth Conference
2025-07-29 16:05U:PLSENews ReleasePulse Biosciences Schedules Second Quarter 2025 Business Updates and Financial Results Conference Call for August 12, 2025
2025-07-16 16:05U:PLSENews ReleasePulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-05-23 16:05U:PLSENews ReleasePulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-05-08 16:05U:PLSENews ReleasePulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results
2025-05-06 16:05U:PLSENews ReleasePulse Biosciences To Present at the BofA Securities 2025 Health Care Conference
2025-05-01 07:00U:PLSENews ReleasePulse Biosciences' Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting
2025-04-25 16:05U:PLSENews ReleasePulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-04-24 16:05U:PLSENews ReleasePulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025
2025-04-23 07:00U:PLSENews ReleasePulse Biosciences' Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting
2025-03-27 16:05U:PLSENews ReleasePulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results
2025-03-26 16:05U:PLSENews ReleasePulse Biosciences To Present at the 24th Annual Needham Virtual Health Care Conference
2025-03-07 08:00U:PLSENews ReleasePulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025
2025-03-04 08:00U:PLSENews ReleasePulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-02-20 16:05U:PLSENews ReleasePulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference
2025-02-04 08:00U:PLSENews ReleasePulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer
2025-01-30 08:00U:PLSENews ReleasePulse Biosciences' Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting
2025-01-21 07:00U:PLSENews ReleasePulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360degree Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium